evaluation of obese child
DESCRIPTION
Evaluation of Obese Child. Marlene Rodriguez, MD FAAP La Clinica de la Raza Peer Review July 29, 2006. Role of Provider in Obesity Prevention. Screen weight status using BMI Routinely deliver obesity prevention messages (regardless of wt) during well child exams Order appropriate lab tests - PowerPoint PPT PresentationTRANSCRIPT
Evaluation of Obese Child
Marlene Rodriguez, MD FAAP
La Clinica de la Raza
Peer Review
July 29, 2006
Role of Provider in Obesity Prevention Screen weight status using BMI Routinely deliver obesity prevention
messages (regardless of wt) during well child exams
Order appropriate lab tests Follow-up and/or refer
Prevalence of Childhood Obesity
CA 5th highest prevalence of pediatric overweight for 2-5 year old
Prevalence of overweight preschool children and adolescents has doubled between 1976-1980 and 1999-2002 and more than tripled for school aged children.
1/2 overweight school age children and 1/3 overweight pre-schoolers become overweight adults
Increasing incidence DMT2 4.1 per 1000 in children Source: CHDP Provider Information Notice No.: 05-16
AMA Recommended Behaviors for Obesity Prevention and Treatment
Breastfeed Increase Physical Activity Limit TV and Screen time Eat more fruits and veggies Eat Breakfast Daily Eat out less often, avoid fast food Limit Portion Sizes Limit sugar-sweetened beverages
Overweight SensitivityAvoid: Replace with:
Obese, heavy, overweight, fat Unhealthy weight
Ideal Weight Healthy weight
Fix the child Family Behavior Change
Focus on weight Focus on Lifestyle
Diets or “bad foods” Healthier food choices
Exercise Activity or play
Obesity Prevention at WCC Assess all children for obesity at all well
child checks starting at age 2 Use Body Mass Index (BMI) to screen
for obesity Plot BMI on BMI growth chart
Diagnostic Categories <5% Underweight 5-84% Healthy Weight 85-94% Overweight 95-98% Obese >99% Proposed Category of
“Extreme Obesity” not yet on BMI charts
BMI 99% Cut-Points (kg/m2)Age Years Boys Girls
5 20.1 21.5
6 21.6 23.0
7 23.6 24.6
8 25.6 26.4
9 27.6 28.2
10 29.3 29.9
11 30.7 31.5
12 31.8 33.1
13 32.6 34.6
14 33.2 36.0
15 33.6 37.5
16 33.9 39.1
17 34.4 40.8
Obesity Prevent at WCC cont. Measure blood pressure using age and size
appropriate cuff Obesity Risk Factors based on Hx and Exam Take Focused Family Hx
Obesity DMT2 CVD such as HTN, cholesterol Early death from stroke or cardiovascular disease
(age <55)
Assess for Other Causes of Obesity Is there Developmental delay? Is the child short for his weight? Are there physical findings such as
hypogondadism? Was there early hypotonia or poor
feeding? If yes, then consider referral for genetic
counseling or endo evaluation.
Laboratory Evaluation for Overweight Children > age2
BMI 85-94% WITH RISK FACTORS
Fasting Lipids
Repeat Every 2 years if normal
Laboratory Evaluation for Overweight Children > age10
BMI 85-94% WITHOUT RISK FACTORS
Fasting Lipid Profile
Laboratory Evaluation for Overweight Children > age10
BMI 85-94% WITH RISK FACTORS
Fasting Lipid Profile ALT & AST Fasting Glucose Fasting Insulin* may support dx of insulin resistance
(*La Clinica recommendation not part of official guidelines.)
Repeat Every 2 years if normal
Laboratory Evaluation for Obese Children > age 10
BMI >95% REGARDLESS OF RISK FACTORS
Fasting Lipid Profile ALT & AST Fasting Glucose Fasting Insulin* may support dx of insulin resistance
(*La Clinica recommendation not part of official guidelines.)
Urine microalbumin or microalbumin/creatine ratio (Stanford Recommendation)
Repeat Every 2 years if normal
CHDP Risk Factors FHx of Diabetes Race/ethnicity:
Black, Hispanic, American Indian, Asian, Pacific Islander, Native Alaskan
Signs of Insulin Resistance Acanthosis Nigrans PCOS HTN Dyslipidemia
< 30 minutes of activity per day or consistently unbalanced diet
Source: CHDP Provider Information Notice No.: 05-16
CHDP Lab Recommendations Overweight Children > age 5
BMI 85-94%
WITH AT LEAST 2 CHDP RISK FACTORS
Fasting Glucose and Cholesterol
Source: CHDP Provider Information Notice No.: 05-16
Abnormal Labs
Elevated Transaminase Levels Check alpha-1 antitrypsin, ceruloplasm, ANA and
hepatitis antibodies Liver U/S detects NAFLD but does not predict
fibrosis Liver Bx to r/o fibrosis
Elevated Lipid Panel Dietary Counseling, Lifestyle Modification AHA recommendation to start statins in some
children still controversial
Abnormal Labs
Elevated Transaminase Levels Check alpha-1 antitrypsin, ceruloplasm, ANA and
hepatitis antibodies Liver U/S detects NAFLD but does not predict
fibrosis Liver Bx to r/o fibrosis
Abnormal Labs Cont.
Abnormal Fasting Glucose GTT (3 hour) with fasting glucose and insulin levels If the above are abnormal refer to Endo at CHO
Criteria for DMT2 Criteria for DMT2
Fasting glucose >126 mg/ml Casual glucose >200 mg/ml
Impaired glucose tolerance: Fasting glucose >100 mg/ml Casual glucose >140 mg/ml
Obesity Co-Morbities NAFLD/NASH Sleep Apnea SCFE Asthma PCOS Self-image/self-esteem Depression
Other Targeted Lab Tests ECG, echocardiography in severe obesity Liver U/S or bx if abnl LFTs Urine Microalbumin/creatine ratio Polysomnography Skeletal radiographs (knee,hip,spine) Plasma 17-OH progesterone, plasma
DHEAS, androstenedione, testosterone (free and total), LH and FSH measurements
Genetic testings (FISH, fragile X)
NAFLD/NASH Similar to alcoholic liver disease but in people
who do not drink Silent elevation of AST/ALT Most common cause of Hepatitis in US
pediatric population Male gender, Hispanic ethnicity, increasing
obesity are risk factors Require bx for DX, but changes seen with US Can go on to cirrhosis and transplant No way to determine which NAFLD pt will go
onto fibrosis
Staged Treatment
Stage 1: Prevention Plus
Stage 2: Structured Weight Management
Stage 3: Comprehensive Multidisciplinary Intervention
Stage 4: Tertiary Care Intervention
Counseling the Overweight ChildBrief Focused Advise
Step 1: Engage the Patient/Parent How do you feel about your child’s wt?
Step 2: Share Information Your child’s current weight puts him/her at
risk for diabetes, heart dz, etc.. Use BMI graphic from HEAC
Effective Communications with Families Kaiser Permanente 2004
Counseling the Overweight ChildBrief Focused Advise
Step 3: Determine if Parent RECEPTIVE to discussion about child’s weight:
If YES then move onto Step 4
If NO, determine if labs need to be ordered, and set up follow-up to discuss
results. This is one way to initiate a conversation about weight and health.
Effective Communications with Families Kaiser Permanente 2004
Counseling Obese Child Cont. Step 4: Make a Key Advise Statement
I would strong encourage you to… Get up and play hard at least one hour/day Cut back on screen time to <2 hours/day Eat at least 5 helpings of fruits & veggies/day Cut back on sweetened drinks such as soda, juice, sports
drinks
Step 5: Arrange for Follow-up Let’s set up future appt to talk about how things are
going
Effective Communications with Families Kaiser Permanente 2004
Stage 2: In Clinic Structured Weight Management
Referral to La Clinica Nutritionist
Enrollment in Weight Management for Children Classes
Stage 3: Comprehensive Multidisciplinary Intervention Referral to Healthy Hearts
Part of Cardiology Dept at CHO Formerly Heathly Eating Active Living
(HEAL) clinic Requires Fasting glucose, insulin, ALT,
AST, lipid panel, Hgb AIC Go through referral specialist There is now a waitlist
Stage 4: Tertiary Care Intervention
Referral to Stanford or UCSF
Medications
Very Low Calorie Diet
Bariatric Surgery
La Clinica Resources
Pediatric Obesity Taskforce 2nd Thursday every month 12:30-1:30pm at TV
Obesity Progress Notes Two versions
Soon to roll out Obesity Registry Fundraiser at Yoshi’s to benefit Childhood
Obesity Prevention Health-e-resource.com
Sources
CHDP Provider Information Notice No.: 05-16Office Evaluation of the Obese Child: New Expert Committee
Recommendations. L.D. Hammer, MD. Practical Strategies for Managing and Preventing Childhood Obesity Conference.
Expert Committee Recommendations on Assessment, Prevention and Treatment of Child and Adolescent Overweight and Obesity 2007 NICHQ
Counseling the Overweight Child: A training for CHDP providers. CHDP Statewide Nutrition Subcommitee December 2008
Pre-Diabetes in Kids and Adolescents. Sue Haverkamp, MD MSPH, La Clinica de la Raza, Peer Review 31 May 2006